Biomics Biopharma (ASX:BBM) Total Tax Payable : A$0.00 Mil (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Total Tax Payable?

Biomics Biopharma's Total Tax Payable for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma Total Tax Payable Historical Data

The historical data trend for Biomics Biopharma's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Total Tax Payable Chart

Biomics Biopharma Annual Data

Trend

Total Tax Payable

Biomics Biopharma Semi-Annual Data

Total Tax Payable

Biomics Biopharma Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Biomics Biopharma Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Total Tax Payable

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines